TOP STORIES

• REGULATORY Ex-Minister Tamura Hightlights Need for Rewarding Innovation towards FY2024 Drug Reform
  January 17, 2023

• ORGANIZATION Japan Pharma Lobbies Look Set to Shift to Okada/Ueno Leadership towards FY2024 Reform
  January 17, 2023

• BUSINESS Alzheimer’s Med Lecanemab Submitted in Japan: Eisai
  January 16, 2023

• REGULATORY Experts Call for Deregulations for Orphan Support, English Dossiers to Foster Biotech Ecosystem
  January 16, 2023

• BUSINESS Daiichi Sankyo Files First Home-Developed mRNA COVID Vaccine in Japan
  January 16, 2023

• BUSINESS Janssen Vows to Offer New Positions for Employees Shown Exit Door: 1st Labor Talks
  January 13, 2023

• REGULATORY PMP, Off-Patent Drug Rules to Be Major Topics for 2024 Reform: MHLW Pharma Management Director
  January 12, 2023

• BUSINESS Eisai Files Alzheimer’s Med Lecanemab in Europe
  January 12, 2023

• ORGANIZATION FPMAJ Chief Poised to Push Rethink of Price Revision Rules towards FY2024 Reform
  January 11, 2023

• BUSINESS Leqembi Likely to Hit Peak Sales after 2030, US$26,500 Price Matches Value: Eisai CEO
  January 10, 2023

• BUSINESS Lecanemab Nabs Accelerated Approval in US, Set to Hit Market Late January
  January 10, 2023

• REGULATORY MHLW Eyes April Proposal to Push Generic Industry Shake-Up: Asst. Vice Minister
  January 6, 2023

• BUSINESS Japan Likely to See Generic Listing for Azilva, Zytiga in 2023; Xarelto AG Rivals Too
  January 5, 2023

• TRENDS Top 10 PHARMA JAPAN Articles in 2022
  December 28, 2022

• REGULATORY PMDA Says “Slow Cartagena Review” Is Urban Legend, Set to Dispel Misconception
  December 27, 2022

• REGULATORY Japan Approves Sanofi’s PD-1 Inhibitor, Teikoku’s Donepezil Tape and More
  December 26, 2022

• BUSINESS Janssen Labor Union to Hold 1st Bargaining Session as Early as Jan. 11
  December 23, 2022

• REGULATORY Special PMP Increase to Offset 95% of Price Cuts for 150 Products: FY2023 Revision
  December 22, 2022

• BUSINESS Janssen Japan Employees Form Labor Union to Counter Closing of Positions
  December 21, 2022

• BUSINESS Kissei Won’t Change 2025 Targets Despite Linzagolix Setback, Decide US Plan by March
  December 20, 2022

ページ

• « 先頭
• ‹ Prev
• …
• 60
• 61
• 62
• 63
• 64
• 65
• 66
• 67
• 68
• …
• Next ›
• 最終 »